Tungsten Alloy PET Containers

Tungsten Alloy PET Containers Picture

1. What Are Tungsten Alloy PET Containers?
Tungsten alloy PET containers are radiation shielding containers used for the packaging, transportation, temporary storage, and handling protection of positron-emitting radiopharmaceuticals such as Fluorine-18 fluorodeoxyglucose (¹⁸F-FDG) and Gallium-68 (⁶⁸Ga) in PET procedures. CTIA’s tungsten alloy PET containers are manufactured from W-Ni-Fe tungsten heavy alloy, providing effective attenuation of γ-rays emitted by radiopharmaceuticals, reducing radiation exposure during drug preparation and operation, and supporting safe use in nuclear medicine applications.

2. Features of CTIA’s Tungsten Alloy PET Containers
(1) Effective Gamma-Ray Shielding: Providing reliable attenuation of γ-rays from PET radiopharmaceuticals through high density of 17.0–18.5 g/cm³ and high atomic number, reducing radiation leakage during handling and storage.
(2) Compact and Lightweight Structure: Enabling smaller dimensions and reduced weight while maintaining required shielding performance, improving portability and operational convenience.
(3) Durable Mechanical Performance: Offering high strength, hardness, and wear resistance to withstand transportation, handling, and repeated daily use while maintaining structural stability.
(4) Optimized Operation and Maintenance: Supporting convenient radiopharmaceutical transfer and injection procedures with smooth surfaces that facilitate cleaning and disinfection.
(5) Lead-Free Safety: Using lead-free tungsten alloy materials to eliminate lead contamination risks in long-term medical applications.

3. Applications of CTIA’s Tungsten Alloy PET Containers
(1) Radiopharmaceutical Transportation: Supporting the safe transfer of ¹⁸F-FDG, ⁶⁸Ga, and other radiopharmaceuticals from production centers to hospitals or injection areas while reducing radiation exposure during transportation.
(2) Temporary Radiopharmaceutical Storage: Providing shielding protection for radiopharmaceutical storage before PET examinations and reducing radiation levels in working environments.
(3) Radiopharmaceutical Dispensing Protection: Supporting drug extraction, dispensing, and dose preparation procedures to reduce radiation exposure during manual operations.
(4) Injection Procedure Protection: Reducing radiation exposure to hands and operators during radiopharmaceutical transfer and injection with compatibility for 2 cc, 3 cc, and 5 cc syringes.
(5) PET Imaging Applications: Supporting radiopharmaceutical protection during PET/CT (Positron Emission Tomography/Computed Tomography) and PET/MR (Positron Emission Tomography/Magnetic Resonance) imaging procedures.

4. Specifications of CTIA’s Tungsten Alloy PET Containers
(1) Materials: W-Ni-Fe
(2) Tungsten Content: 90%–97%
(3) Density: 17.0–18.5 g/cm³
(4) Dimensions: Outer diameter 90–100 mm, height 120–150 mm, wall thickness 20–40 mm, customizable
(5) Structures: Radiopharmaceutical vial containers, transport containers, syringe shields, and customized shielding structures

CTIA GROUP has accumulated nearly 30 years of experience in tungsten alloy manufacturing, supported by advanced powder metallurgy processes and precision machining technologies. CTIA manufactures tungsten alloy PET containers with application-specific structures and precise dimensions, meeting nuclear medicine requirements for radiopharmaceutical packaging, radiation protection, and long-term operational reliability.

For any inquiry, please contact tungsten alloy manufacturer: CTIA GROUP

Email: sales@chinatungsten.com

Tel: 0086 592 5129696 / 0086 592 5129595

Website: tungsten-alloy.com

WeChat:

Business Wechat of CTIA GROUP